Find Addiction Expert Witnesses & Trial-ready Behavioral Health Experts

Addiction medicine sits at the intersection of pharmacology, psychiatry, and regulatory compliance, and juries rarely arrive in the courtroom with a working understanding of any of those disciplines. An Addiction & Recovery expert provides three distinct forms of value: they establish the applicable clinical standard of care, they translate complex neurological and behavioral science into accessible language, and they offer an independent clinical opinion that courts require before certain causation or damages arguments can be advanced.

In prescribing-related matters, the expert's role often centers on whether a physician's conduct conformed to accepted addiction medicine practice — including the use of prescription monitoring programs, dosage thresholds, documentation of risk assessments, and the recognition of aberrant drug-related behaviors. In treatment adequacy cases, the expert evaluates whether a facility's protocols for detoxification, medication-assisted treatment, or aftercare planning met the standard a similarly situated provider would have followed. Either way, the expert must be credible to both the court and a lay jury, which requires a combination of clinical depth and communication skill that not every qualified clinician possesses.

The most frequently litigated matters in this specialty fall into several recognizable clusters. Opioid prescribing malpractice cases — in which a prescriber is alleged to have departed from accepted standards in initiating, continuing, or failing to taper a controlled-substance regimen — represent a substantial share of engagements. Closely related are wrongful-death claims arising from fatal overdoses in which the prescribing conduct or the failure to refer for addiction treatment is alleged to have been a proximate cause.

Residential and outpatient treatment facility negligence forms a second cluster. These cases often involve inadequate withdrawal monitoring, failure to diagnose a co-occurring psychiatric condition, or the premature discharge of a patient who subsequently suffered serious harm. Nursing home neglect cases can raise addiction-adjacent issues when residents are prescribed psychoactive or opioid medications without adequate monitoring for dependency or diversion.

Personal-injury cases frequently implicate addiction as a damages or comparative-fault issue — for example, when a plaintiff had a pre-existing substance-use disorder that a defendant claims was the real cause of an injury or loss. Workers' compensation matters raise similar questions when prescription dependency arises from a workplace injury treatment plan. Finally, pharmaceutical and mass-tort litigation involving habit-forming medications may require addiction medicine experts to address both labeling adequacy and the clinical realities of dependency development.

The directory applies a structured review process before any Addiction & Recovery expert is listed. Verification begins with licensure: each expert's medical license is confirmed as active in the state or states identified in the profile, using the relevant state medical board's public practitioner database. Where a license has lapsed, been placed on probationary status, or been subject to disciplinary action, that information is assessed for disclosure and, in material cases, results in the profile not being published.

Board certification is confirmed through the issuing board's practitioner lookup — not through self-report alone. For addiction medicine specialists, the relevant certifying bodies include the American Board of Addiction Medicine and the subspecialty certification offered through the American Board of Preventive Medicine; for addiction psychiatrists, the relevant body is the American Board of Psychiatry and Neurology. DEA registration status is reviewed for experts whose opinions are likely to involve controlled-substance prescribing analysis. Profiles are subject to periodic re-review, and attorneys are encouraged to request an updated CV directly when retention is under active consideration.

A typical engagement begins with the transmission of relevant records — prescribing histories, treatment facility charts, pharmacy dispensing records, toxicology reports, and any prior expert reports in the matter. The expert will review those materials and provide an initial case assessment indicating whether, in their clinical opinion, the facts support the theories at issue. This preliminary assessment is usually delivered in writing, though some experts prefer a call to discuss before committing conclusions to paper.

If the engagement proceeds, the expert will prepare a written report meeting the disclosure requirements of the applicable court rules. In federal matters, this means a report complying with Federal Rule of Civil Procedure 26(a)(2)(B); state courts have varying requirements. The expert should be prepared to explain the methodology underlying each opinion — the clinical guidelines, peer-reviewed literature, or professional standards on which the opinion rests — because that methodology will be scrutinized at deposition and may be the subject of a Daubert or Frye motion.

Deposition preparation is a distinct phase of the engagement and should be budgeted accordingly. Addiction medicine experts who have testified previously will generally move through deposition preparation more efficiently than first-time witnesses, but all experts benefit from at least one focused session with trial counsel before being deposed. The expert's fee schedule should be obtained in writing before records are transmitted, and any limitation on availability — for example, a trial commitment in another matter — should be surfaced early.

Expert testimony in addiction-related matters is subject to the same admissibility framework as any other medical expert opinion. Under Federal Rule of Evidence 702 and the Daubert standard applied in federal courts (and adopted in modified form by many states), the trial court acts as gatekeeper, evaluating whether the expert's methodology is scientifically valid, whether it has been applied reliably to the facts of the case, and whether it will assist the trier of fact in understanding the evidence.

Addiction medicine presents specific methodological considerations. Standard-of-care opinions should be grounded in published clinical guidelines — such as those issued by professional societies with recognized authority in addiction medicine or pain management — rather than in the expert's personal clinical preferences. Causation opinions in opioid cases often involve a differential diagnosis methodology, which courts have generally found to be an acceptable framework when it is applied systematically and documented clearly. Experts whose opinions rest on peer-reviewed literature rather than on unpublished internal protocols tend to fare better under judicial scrutiny. Retaining counsel should ask any proposed expert to identify, before designation, the specific methodological foundation for each opinion they intend to offer.